Top compounds associated with response to LGALS9B


Feature Type Standardized
Nominal ANOVA
mRNA tanespimycin:bortezomib (250:1 mol/mol) CTRPv2 pan-cancer AAC 0.046 0.2
mRNA AA-COCF3 CTRPv2 pan-cancer AAC -0.043 0.2
mRNA NVP-231 CTRPv2 pan-cancer AAC -0.04 0.2
mRNA BRD9876 CTRPv2 pan-cancer AAC -0.046 0.2
mRNA vorinostat:carboplatin (1:1 mol/mol) CTRPv2 pan-cancer AAC -0.041 0.2
mRNA ML320 CTRPv2 pan-cancer AAC -0.043 0.2
mRNA compound 1B CTRPv2 pan-cancer AAC 0.046 0.2
mRNA BRD6340 CTRPv2 pan-cancer AAC -0.041 0.2
mRNA WAY-362450 CTRPv2 pan-cancer AAC -0.044 0.3
mRNA Rapamycin gCSI pan-cancer AAC -0.063 0.3
Download CSV